Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

26.32
+1.335.32%
Post-market: 26.350.0300+0.11%19:59 EST
Volume:18.35M
Turnover:480.95M
Market Cap:30.20B
PE:42.65
High:26.45
Open:25.90
Low:25.74
Close:24.99
52wk High:26.45
52wk Low:12.47
Shares:1.15B
Float Shares:1.14B
Volume Ratio:2.08
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6171
EPS(LYR):-1.4492
ROE:9.71%
ROA:5.45%
PB:4.17
PE(LYR):-18.16

Loading ...

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Teva Pharmaceutical (TEVA)

TIPRANKS
·
7 hours ago

Teva Pharmaceutical Industries (NYSE:TEVA): Evaluating Valuation After European Approval for Key Biosimilars

Simply Wall St.
·
16 hours ago

Jefferies Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)

TIPRANKS
·
Yesterday

Teva Rise Innovation Platform Might Change The Case For Investing In Teva Pharmaceutical Industries (TEVA)

Simply Wall St.
·
Yesterday

Teva Pharmaceutical Says Denosumab Biosimilars Get European Commission Marketing Approval

MT Newswires Live
·
Nov 25

Teva, Amgen, Rithm, Fastly, Medtronic: Major Stock Moves!

TIPRANKS
·
Nov 22

Jury Convicts Done Global Founder In Adderall Distribution Scheme: WSJ Report

Benzinga
·
Nov 20

BRIEF-Teva Launches Rise A Global Open Innovation Platform To Accelerate Ai, Industry 4.0, Smart Manufacturing, Digital Health And Biotech Breakthroughs For Pharma’S Biggest Challenges

Reuters
·
Nov 19

Teva Launches Rise Platform for Startups to Solve Pharmaceutical Challenges

MT Newswires Live
·
Nov 19

Teva Launches Rise: a Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

THOMSON REUTERS
·
Nov 19

Analysts Conflicted on These Healthcare Names: Teva Pharmaceutical (TEVA) and Purple Biotech (PPBT)

TIPRANKS
·
Nov 19

Teva Pharma: Austedo, Austedo XR demonstrate positive real-world impact

TIPRANKS
·
Nov 08

Teva Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Nov 07

Teva Canada - Ramq to Apply 'Lowest Price' Method to Methylphenidate From Dec 11, 2025

THOMSON REUTERS
·
Nov 06

Teva Canada Welcomes Ramq Reimbursement Update Supporting Access to Adhd Treatments

THOMSON REUTERS
·
Nov 06

Truist Raises Price Target on Teva Pharmaceutical Industries to $32 From $25, Keeps Buy Rating

MT Newswires Live
·
Nov 06

Teva’s Earnings Call Highlights Growth Amid Challenges

TIPRANKS
·
Nov 06

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Benzinga
·
Nov 06

Stock Track | Teva Pharmaceutical Soars 15.52% on Strong Q3 Results and Improved 2025 Outlook

Stock Track
·
Nov 05

U.S. Stock Movement | Teva Pharmaceutical (TEVA.US) Surges Nearly 13% Pre-Market as Q3 Revenue and Adjusted EPS Beat Expectations

Stock News
·
Nov 05